Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Oncolytics Biotech, Inc. (NQ: ONCY)
2.340 USD  -0.030 (-1.27%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Oncolytics Biotech, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Oncolytics Biotech® Inc. to Present at 2013 Jefferies Global Healthcare Conference
June 04, 2013
from PR Newswire
Free Research Reports on GILD, MRK, ONCY and PFE Issued by the Bedford Report
May 23, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Oncolytics Biotech® Inc. Meets Primary Endpoint for First Stage of U.S. Phase 2 Metastatic Melanoma Trial
May 22, 2013
from PR Newswire
Media Advisory - Oncolytics Biotech® Inc. to Present at Bank of America Merrill Lynch Health Care Conference
May 14, 2013
from PR Newswire
Oncolytics Biotech® Inc. Announces Director Election Results from its Annual and Special Meeting of Shareholders
May 10, 2013
from PR Newswire
Oncolytics Biotech® Inc. Announces First Quarter 2013 Results
May 09, 2013
from PR Newswire
Oncolytics Biotech® Inc. Announces Details of 2013 Annual and Special Meeting of Shareholders
May 06, 2013
from PR Newswire
Media Advisory - Oncolytics Biotech® Inc. to Present at 12th Annual Needham Healthcare Conference
April 29, 2013
from PR Newswire
Free Research Reports on FINL, ONCY, PCS and RPRX Issued by the Bedford Report
April 01, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Oncolytics Biotech® Inc. Meets Primary Overall Statistical Endpoint in U.S. Phase 2 Study of REOLYSIN® in Squamous Cell Lung Cancer
March 28, 2013
from PR Newswire
FDA's New "Breakthrough" Designation Allows New Drugs to Gain Approval after Just 1 Round of Testing
March 19, 2013
Five Star Equities Provides Stock Research on Oncolytics Biotech and XOMA Read More
from Marketwired News Releases
Oncolytics Biotech® Inc. Announces 2012 Year End Results
March 14, 2013
from PR Newswire
Oncolytics Biotech® Inc. Completes Patient Enrollment in U.S. Phase 2 Study of REOLYSIN® in Non-Small Cell Lung Cancer
March 05, 2013
from PR Newswire
Media Advisory - Oncolytics Biotech® Inc. to Present at RBC Capital Markets 2013 Healthcare Conference
February 25, 2013
from PR Newswire
Oncolytics Biotech® Inc. Announces Closing of Common Share Offering
February 25, 2013
from PR Newswire
Oncolytics Biotech® Inc. Announces Addition to Senior Management Team
February 20, 2013
from PR Newswire
IIROC Trade Resumption - Oncolytics Biotech Inc.
February 20, 2013
from Newsfile Corp News Releases
IIROC Trade Halt - Oncolytics Biotech Inc.
February 20, 2013
from Newsfile Corp News Releases
Oncolytics Biotech® Inc. Announces Pricing of Common Share Offering
February 20, 2013
from PR Newswire
Oncolytics Biotech® Inc. Announces Common Share Offering
February 19, 2013
from PR Newswire
Free Research Report on Oncolytics Biotech Inc., Heartware International Inc., Sigma-Aldrich Corp., Carbo Ceramics Inc. and KT Corp.
February 14, 2013
from Marketwired News Releases
FDA Approved a Total of 39 New Drugs in 2012 -- Fifteen Year High
February 11, 2013
Research Driven Investing Provides Stocks Research on AEterna Zentaris and Oncolytics Biotech Read More
from Marketwired News Releases
Free Research Reports on ONCY, CLSN, ETRM and MOH Issued by the Bedford Report
February 11, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Oncolytics Biotech® Inc. Announces Additional Positive REOLSYIN® Clinical Trial Data from Phase 2 Study in Squamous Cell Carcinoma of the Lung
February 08, 2013
from PR Newswire
Oncolytics Biotech® Inc. Announces Positive REOLSYIN® Clinical Trial Data Presented at ASCO Gastrointestinal Cancers Symposium
January 28, 2013
from PR Newswire
The Real Story Behind STAA, ALC, RGLS and ONCY
January 02, 2013
from Marketwired News Releases
Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases
January 02, 2013
Five Star Equities Provides Stock Research on Incyte and Oncolytics Biotech Read More
from Marketwired News Releases
Free Research Reports on ONCY, RFMD, SCTY and VECO Issued by the Bedford Report
December 14, 2012
The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Oncolytics Biotech Inc. Announces Positive Top Line REOLYSIN® Data for First Endpoint in Randomized Phase III Study in Head and Neck Cancers
December 13, 2012
from PR Newswire
Oncolytics Biotech Inc. Announces Addition to Senior Management Team
November 12, 2012
from PR Newswire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here